Spondyloepiphyseal dysplasia is a disorder characterized by abnormalities ofgrowth. Previous studies of this disorder have identified a significant incidence of associated hearing loss. Hearing loss has been reported to occur in 25 to 30% of affected patients. To date, all reports of associated hearing loss have indicated the presence ofa sensorineural component.
Introduction
Spondyloepiphyseal dyspl asia (SED) is a rare, type II collagen disorder that is defined and diagnosed by its characteri stic clinic al and radiolo gic feature s. There are two variants of the disorder: SED congenita and SED tarda. They differ only in the inheritance pattern and age of onset; SED congenita is autosomal-dominant and occurs during early childhood, while SED tarda is autosomal-rece ssive and develops during teenage years. The patient described in this report had the congenita form .
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Pseudomembranous colitis has beenreported with nearly all antibacterial agents,includinglevofloxacin, andmayI 'nge in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who press• . with diarrhea subsequent to the administration ot any antibacterial agent. As with other quinolones. disturbances 01bloodglucose. incl uding symptomatic hyper-andhypoglycemia, havebeen reported. usua lly in diabetic patients receiving concomitanttreatmentwith anoral hypoglycemic agent(e.g. , glybur ide/glibenclamide) or with insulin. In these patients. careful moni toringof bloodglucose is recommended. If a hypoglycemic react ionoccurs in a patien t being treated with leveffoxacin. levotlcxacinshouldbediscontinued immediately andappropriate therapy should beinitiated immediately. ( fixation. Approximately 6 months later, her bone conduction at 2 kHz had worsened to a mild sensorineural component with stable air conduction thresholds. By April 1993 (age: 6 yr, 7 mo), the patient' s unmasked bone conduction thresholds had also worsened at 4 kHz, and she had a mild sensorineural component at 2 to 4 kHz in the right ear (figure 2). The worsening bone conduction line allowed us to obtain masked bone conduction responses for the left ear without the risk of overmasking. Results indicated the presence of a mixed hearing loss in the left ear, with air/bone gaps of approximately 30 dB at 0.5 to 4 kHz. Monaura lly aided speech discrimination appeared to be exce llent bilaterally. Air and bone conduction thresholds remained esse ntially unchanged through February 1995, except for recovery of the unmasked bone conduction threshold at 4 kHz.
In Novem ber 1995 (age: 9 yr, 3 mo), another evaluation indica ted that her conduction thresholds in the right ear had decreased significantly since February 1995, but her bone conduction results were unchanged. Tympanometry contin ued to indicate normal middle ear compliance and pressure in both ears (0.8 cc static compliance at adaPa).
Speech discrimination ability was exce llent in both ears

( 100%) .
In 1996,an evaluation was performed with insert phones, which permitted contralateral masking to each ear without ove rmasking and allowed us to better delineate bone the femoral epiphyses and flattening of the metaphysis. Hypoplasia/dysplasia of the odontoid process and dysplasia at C4, C5, and LI were also noted. Her forearm , particularly the radius, was unusually short. All of these features were consistent with a very narrow range of differential diagnoses, of which SED congenita was the most likely, followed by multiple epiphyseal dysplasia and type IV mucopolysaccharidosis (Morquio' s syndrome).
Although multiple epiphysea l dysplasia was initially considered in the differential diagnosis, it was quickly ruled out because the involvement of the vertebral column was much more consistent with SED. Morquios syndrome was also considered because it often has many of the same features. However, the results of the patient ' s mucopolysaccharide screen were within the normal range (3 units), and there was no involvement of the hands and no corneal opacification, which are characteristic of Morquio' s syndrome. Thus, the diagnosis of SED was established. Because of the known associated anoma lies, in 1989 she was referred for ophthalmologic and audiologic evaluations. Since 1995, she has been followed at the University of Massachusetts Medical Center by the Department of Otolaryngology.
In 1989, the patient had her first hearing evaluation (patient's age: 2 yr, 6 mo). The results of her behavioral audiologic tests suggested a mild to moderate hearing loss in the sound field at 0.25 to 4 kHz. Tympanometry results at that time were consistent with normal middle ear compli ance and pressure (-100 daPa). An auditory brainstem response test was performed I month later in order to obtain an objective measurement of the hearing sensitivity in each ear. The results indicated a moderate bilateral hearing loss for clicks and 2-and 4-kHz tone bursts. Unmasked bone conduction responses to click stimuli indicated the presence of a conductive component in at least one ear. The patient was subsequently fitted binaurally with behind-the-ear hearing aids.
A followup behavioral audiologic evaluation with play audiometry was performed in early 1991 (patient's age: 4 yr, 7 mo). This test revealed the presence of a mild hearing loss in the right ear and a moderate hearing loss in the left ear, with normal bone conduction responses at 0.5 to 4 kHz.
In late 1991 (age: 5 yr, 3 mo), her air conduction thresholds and tympanograpy results were essentially unchanged ( figure I ) . Higher frequencies were also tested at that time. The results indicated the presence of a moderate to severe hearing loss in the right ear and a severe to profound hearing loss in the left ear at 6 to 8 kHz. Also, a slight depression (Carhart' s notch) in the unmasked bone conduction threshold at 2 kHz was observed; this depression is often a characteristic of stapes cond uction thresholds in eac h ear. An air/bone gap of approx imate ly 40 dB was seen in the left ea r at 0.25 to 4 kHz, and a gap of 15 to 20 dB was fo und in the right ea r at 0.25 to I kHz and at 4 kHz. Th e hearing loss con tinued to be sensorineura l in nature at 2 kHz in the right ea r. Speec h discri minati on had wo rse ned slig htly (88 %). Ty mpa nometry was again normal ( 1.3 cc static co mpliance in the right ear, 1.7 cc in the left) at 0 daPa pressure, reflecti ng normal middle ear function. Th e patient underwen t a Weber' s test, whic h lateralized to the left, and a Rinne' s test (5 12 Hz), whic h was negative on the left and positi ve on the rig ht.
An eva luat ion co nducted in Jun e 1997 (age: 10 yr, 10 mo) indicated that the mild hearing loss in the rig ht ear was primari ly se nsorineura l, with a slight conductive compo nent at 2 to 4 kHz (figure 3). Ca rhar t's notch was still evide nt. Speech discrimination had co ntinued to dec line, as sco res fell to 80 % in the right ea r and 72 % in the left ear.
In summa ry, result s obtained as ea rly as 1989 indicated the prese nce of a bilateral hear ing loss, as unm asked bone conduction resul ts sugges ted that the re was a co nduct ive component in at least one ear. Air con ductio n thresholds remai ned relatively stab le from 1989 to 1997, with no more than a 5-to 10-dB decline in the right ea r and a 10to 15-dB dec line in the left ear. The heari ng loss in the right ear was predominately sensorineural in nature. How-ever, because of a mask ing dilemm a, it was imp ossible to say whet her there was a conductive co mpo nent in the rig ht ear prior to the onset of the sensorineura l componen t. Speech discrimination appeared to have worsened significa ntly in bot h ea rs. At this point , the patient is doing we ll with bilateral beh ind-the-ear hearing aids, and correc tive surge ry fo r pres umed left stapes fixa tion is being deferred until the chi ld reaches adulthood.
Discussion
Spo ndy loep iphyseal dysplasia was first described by Spranger and Wiedm ann in 1966. 1 Their orig ina l ser ies did not highl ight the inc ide nce of associated hea ring loss. Th ree years later, Fraser et al reported a large series of pat ients with this newly described disorder, and they did repo rt a clear association with hearing loss.' In their series, 8 of 9 patient s had a hearing loss that had begun during childhood (age ra nge : 2 to 12 yr) . The loss was most pro nounce d in the higher frequencies. All cases were se nsori neura l in nat ure. In 1982, Wyn ne-Dav ies and Hall reported a ser ies of 17 patients and noted that roughly 25 % of them had an associated hear ing loss.' However, they did not docu me nt the nature of the loss or provi de info rma tion on their pa tie nts' audiograms. In 1993, Cole et al publ ished a repor t of a case of SE D (associated with a spec ific am ino acid su bstit ution) in whic h the patient de mons trated a progress ive hearing loss that eve ntually became moderate to severe bila tera lly by the time the patie nt had reached 17 years of age. " Data in the literature are limit ed by the rarity of the syn drome, bu t the overall es tima te of hearin g loss assoc iated with SED is 30%.7 Most papers report a loss on the order of 30 to 70 dB at the higher fre quenc ies (4 to 8 kHz) .2.6 The se nsorine ura l hearing loss might be explained by the fac t that the inne r ear has many struc tures that are derived fro m type II collagen. Type II collagen ca n be fo und on the apical and basal surfaces of the epithelium of most of the inner ear, including the cochlea." More spec ifica lly, type II collagen is a significa nt component of the osseous spira l lamina , the spiral limbus, and the tectorial membrane. Abnor malities in thes e structures clearly result in a sensorineura l hearing loss.
A searc h and review of the literature written since Spranger and W iedm ann ' s original descr ipti on in 1966 yie lded no re po rts of an associated hearing loss in the abse nce of a middl e ear infec tion or middle ea r fluid . One case repor t did des cr ibe a condu cti ve loss in the presence of middle ear fluid, which improved foll owin g myr ingotom y and drainage of the ear." Our patient clea rly had a mixe d hearin g loss in the left ear, eve n in the abse nce of middle ea r fluid or ot her middle or outer ear abnormalities.
Based on the documented presence of type II collagen in the coc hlea, it is no surprise that SED is associated with senso rineura l hearin g IOSS.6.8 However, it is also believed that type II co llagen is present in the cartilage that gives rise to the ossicles ." Th erefore, it is surpris ing that there are no reports of SE D associated with mixed hearin g loss.
One possible mech anism of co nductive hearing loss is dama ge to the sy nov ial j oints of the ossicles. In a case se rie s of the sy nov ial j oint complic atio ns of SED, Sa mbrook et al noted cases of chronic synov itis and radio logically evi de nt cho ndroc alcinos is in multiple j oints."Th ey repor ted such complications in larger joints, but they did not specifically address the ossicl es or hea ring status . Nonet heless, it is not impl ausibl e that the same mechanism , which is dri ven by the und erl ying dyspl asia and conseq uent abnormalities in the j oint , co uld affec t the ossi cles and res ult in hearing loss. Seve ral studies in anima l model s have show n an association between typ e II co llage n autoimmunity and otoscleros is.P" ? Th e described mec hanism is a logical one: immunologic tissue dama ge to the cartilag inous co mponents of the oss icles produ ces otos pong iotic lesions. Th ese lesions in turn yie ld the clini cal finding of otosclerosis. Th ese studies we re of autoimmune diseases rather than hereditary dyspl asias, such as SED. Even so, know ing that SED result s in dyspl astic and hypopl astic type II co llagen str uctures, one might expe ct struc tures similar to those described in otosc leros is. Thus the clinical find-182 ings-nam ely the patt ern of hearing loss-would also be ex pec ted to be similar.
Either mechanism wo uld ex plain the obse rved pattern of mixed hearing loss. Mo reover, it is more reasonable to think that a disease of abnormal type II collagen , which is known to be associ ated with senso rineura l hearin g loss, is also ass ociated with co nductive hearin g loss rather than not. With the overwhe lming problems in growth and gait that SED present s patients and their ph ysici ans, perhap s there are other cases of associated conductiv e hearing loss that are being overlo oked. Our young patient' s hearing status has been close ly followed and clearl y demonstrates a mi xed hearing loss with what app ears to be stapedial fix ation.
